At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,024 enrolled
Drug / intervention
Cardiac Resynchronization Therapy Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
In Brief
An observational study evaluating Cardiac Resynchronization Therapy Device for Heart Failure, Congestive. Completed, enrolled 1,024 participants across 93 sites.
Detailed Summary
The purpose of this study is to determine the value of diagnostic data obtained from Medtronic implantable cardioverter defibrillators (ICDs) with cardiac resynchronization therapy (CRT) to evaluate cardiovascular and heart failure related adverse events and health care utilization.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Congestive
CountriesUnited States
CollaboratorsMedtronic
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2004
First PostedJan 2006
Primary CompletionMar 2008
Study CompletionJun 2008
TodayJul 2026
First PostedJan 20, 2006
Enrollment StartJun 1, 2004
Primary CompletionMar 1, 2008
Study CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 20.4 years ago
Interventions
Cardiac Resynchronization Therapy Devicedevice
Patients with an ICD indication, a CRT indication and symptomatic heart failure who are implanted with a Cardiac Resynchronization Therapy Device.